APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gastrointestinal Motility Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Gastrointestinal Motility Drugs Industry Growth and Trends Forecast to 2032

27 December 2025126 pages

Choose your research edition.

Industry ResearchGastrointestinal Motility Drugs Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Gastrointestinal Motility Drugs Industry Growth and Trends Forecast to 2032126 pages · $3,450 USDMarket StructureGlobal Gastrointestinal Motility Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gastrointestinal Motility Drugs Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal Gastrointestinal Motility Drugs Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global Gastrointestinal Motility Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Gastrointestinal Motility Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Gastrointestinal Motility Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gastrointestinal Motility Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Gastrointestinal Motility Drugs include Zhuhai Rundu Pharmaceutical Co., Ltd., Yabao Pharmaceutical Group Co., Ltd., Sichuan Zilinggong Pharmaceutical Co., Ltd., Shijiazhuang Siyao Co., Ltd., Shandong Xinhua Pharmaceutical Co., Ltd., Shandong Fangming Pharmaceutical Group Co., Ltd., Lunan Beite Pharmaceutical Co., Ltd., Jiangxi Huiren Pharmaceutical Co., Ltd. and Jiangsu Jibei Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Gastrointestinal Motility Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Gastrointestinal Motility Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Gastrointestinal Motility Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Gastrointestinal Motility Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Gastrointestinal Motility Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Gastrointestinal Motility Drugs Market by Company

Zhuhai Rundu Pharmaceutical Co., Ltd.

Yabao Pharmaceutical Group Co., Ltd.

Sichuan Zilinggong Pharmaceutical Co., Ltd.

Shijiazhuang Siyao Co., Ltd.

Shandong Xinhua Pharmaceutical Co., Ltd.

Shandong Fangming Pharmaceutical Group Co., Ltd.

Lunan Beite Pharmaceutical Co., Ltd.

Jiangxi Huiren Pharmaceutical Co., Ltd.

Jiangsu Jibei Pharmaceutical Co., Ltd.

Jiangsu Hausen Pharmaceutical Group Co., Ltd.

China Resources Double Crane Pharmaceutical Co., Ltd.

Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd.

Hainan Asia Pharmaceutical Co., Ltd.

Guangdong Annuo Pharmaceutical Co., Ltd.

Disa Pharmaceutical Group Co., Ltd.

Chenxin Pharmaceutical Co., Ltd.

Taj Pharmaceuticals Limited

Sumitomo Pharma Co., Ltd.

Pfizer

Midas Pharma GmbH

Janssen Pharmaceutica

Hanmi Pharm. Co., Ltd.

ANI Pharmaceuticals, Inc.

Abbott

Gastrointestinal Motility Drugs Segment by Type

Domperidone

Metoclopramide

Mosapride

Minaprocaine Bromide

Itopride

Gastrointestinal Motility Drugs Segment by Application

Clinic

Hospital

Other

Gastrointestinal Motility Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gastrointestinal Motility Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gastrointestinal Motility Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gastrointestinal Motility Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Gastrointestinal Motility Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Gastrointestinal Motility Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Domperidone Table 2. Major Company of Metoclopramide Table 3. Major Company of Mosapride Table 4. Major Company of Minaprocaine Bromide Table 5. Major Company of Itopride Table 6. Global Gastrointestinal Motility Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Gastrointestinal Motility Drugs Sales by Type (2021-2026) & (K Units) Table 8. Global Gastrointestinal Motility Drugs Sales Market Share in Volume by Type (2021-2026) Table 9. Global Gastrointestinal Motility Drugs Sales by Type (2021-2026) & (US$ Million) Table 10. Global Gastrointestinal Motility Drugs Sales Market Share in Value by Type (2021-2026) Table 11. Global Gastrointestinal Motility Drugs Price by Type (2021-2026) & (US$/Unit) Table 12. Global Gastrointestinal Motility Drugs Sales by Type (2027-2032) & (K Units) Table 13. Global Gastrointestinal Motility Drugs Sales Market Share in Volume by Type (2027-2032) Table 14. Global Gastrointestinal Motility Drugs Sales by Type (2027-2032) & (US$ Million) Table 15. Global Gastrointestinal Motility Drugs Sales Market Share in Value by Type (2027-2032) Table 16. Global Gastrointestinal Motility Drugs Price by Type (2027-2032) & (US$/Unit) Table 17. North America Gastrointestinal Motility Drugs Sales by Type (2021-2026) & (K Units) Table 18. North America Gastrointestinal Motility Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Gastrointestinal Motility Drugs Sales by Type (2021-2026) & (K Units) Table 20. Europe Gastrointestinal Motility Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Gastrointestinal Motility Drugs Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Gastrointestinal Motility Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Gastrointestinal Motility Drugs Sales by Type (2021-2026) & (K Units) Table 24. Latin America Gastrointestinal Motility Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Gastrointestinal Motility Drugs Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Gastrointestinal Motility Drugs Sales by Type (2021-2026) & (US$ Million) Table 27. Gastrointestinal Motility Drugs Industry Trends Table 28. Gastrointestinal Motility Drugs Industry Drivers Table 29. Gastrointestinal Motility Drugs Industry Opportunities and Challenges Table 30. Gastrointestinal Motility Drugs Industry Restraints Table 31. Global Gastrointestinal Motility Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Gastrointestinal Motility Drugs Revenue Market Share by Company (2021-2026) Table 33. Global Gastrointestinal Motility Drugs Sales by Company (2021-2026) & (K Units) Table 34. Global Gastrointestinal Motility Drugs Sales Share by Company (2021-2026) Table 35. Global Gastrointestinal Motility Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Gastrointestinal Motility Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Gastrointestinal Motility Drugs Major Company Production Sites and Headquarters Table 38. Global Gastrointestinal Motility Drugs Company, Product Type & Application Table 39. Global Gastrointestinal Motility Drugs Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Gastrointestinal Motility Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Gastrointestinal Motility Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Gastrointestinal Motility Drugs Sales by Region (2021-2026) & (K Units) Table 44. Global Gastrointestinal Motility Drugs Sales Market Share in Volume by Region (2021-2026) Table 45. Global Gastrointestinal Motility Drugs Sales by Region (2021-2026) & (US$ Million) Table 46. Global Gastrointestinal Motility Drugs Sales Market Share in Value by Region (2021-2026) Table 47. Global Gastrointestinal Motility Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Gastrointestinal Motility Drugs Sales by Region (2027-2032) & (K Units) Table 49. Global Gastrointestinal Motility Drugs Sales Market Share in Volume by Region (2027-2032) Table 50. Global Gastrointestinal Motility Drugs Sales by Region (2027-2032) & (US$ Million) Table 51. Global Gastrointestinal Motility Drugs Sales Market Share in Value by Region (2027-2032) Table 52. Global Gastrointestinal Motility Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Gastrointestinal Motility Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Gastrointestinal Motility Drugs Sales by Application (2021-2026) & (K Units) Table 55. Global Gastrointestinal Motility Drugs Sales Market Share in Volume by Application (2021-2026) Table 56. Global Gastrointestinal Motility Drugs Sales by Application (2021-2026) & (US$ Million) Table 57. Global Gastrointestinal Motility Drugs Sales Market Share in Value by Application (2021-2026) Table 58. Global Gastrointestinal Motility Drugs Price by Application (2021-2026) & (US$/Unit) Table 59. Global Gastrointestinal Motility Drugs Sales by Application (2027-2032) & (K Units) Table 60. Global Gastrointestinal Motility Drugs Sales Market Share in Volume by Application (2027-2032) Table 61. Global Gastrointestinal Motility Drugs Sales by Application (2027-2032) & (US$ Million) Table 62. Global Gastrointestinal Motility Drugs Sales Market Share in Value by Application (2027-2032) Table 63. Global Gastrointestinal Motility Drugs Price by Application (2027-2032) & (US$/Unit) Table 64. North America Gastrointestinal Motility Drugs Sales by Application (2021-2026) & (K Units) Table 65. North America Gastrointestinal Motility Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Gastrointestinal Motility Drugs Sales by Application (2021-2026) & (K Units) Table 67. Europe Gastrointestinal Motility Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Gastrointestinal Motility Drugs Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Gastrointestinal Motility Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Gastrointestinal Motility Drugs Sales by Application (2021-2026) & (K Units) Table 71. Latin America Gastrointestinal Motility Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Gastrointestinal Motility Drugs Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Gastrointestinal Motility Drugs Sales by Application (2021-2026) & (US$ Million) Table 74. Zhuhai Rundu Pharmaceutical Co., Ltd. Company Information Table 75. Zhuhai Rundu Pharmaceutical Co., Ltd. Business Overview Table 76. Zhuhai Rundu Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Zhuhai Rundu Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio Table 78. Zhuhai Rundu Pharmaceutical Co., Ltd. Recent Development Table 79. Yabao Pharmaceutical Group Co., Ltd. Company Information Table 80. Yabao Pharmaceutical Group Co., Ltd. Business Overview Table 81. Yabao Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Yabao Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio Table 83. Yabao Pharmaceutical Group Co., Ltd. Recent Development Table 84. Sichuan Zilinggong Pharmaceutical Co., Ltd. Company Information Table 85. Sichuan Zilinggong Pharmaceutical Co., Ltd. Business Overview Table 86. Sichuan Zilinggong Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Sichuan Zilinggong Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio Table 88. Sichuan Zilinggong Pharmaceutical Co., Ltd. Recent Development Table 89. Shijiazhuang Siyao Co., Ltd. Company Information Table 90. Shijiazhuang Siyao Co., Ltd. Business Overview Table 91. Shijiazhuang Siyao Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Shijiazhuang Siyao Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio Table 93. Shijiazhuang Siyao Co., Ltd. Recent Development Table 94. Shandong Xinhua Pharmaceutical Co., Ltd. Company Information Table 95. Shandong Xinhua Pharmaceutical Co., Ltd. Business Overview Table 96. Shandong Xinhua Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Shandong Xinhua Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio Table 98. Shandong Xinhua Pharmaceutical Co., Ltd. Recent Development Table 99. Shandong Fangming Pharmaceutical Group Co., Ltd. Company Information Table 100. Shandong Fangming Pharmaceutical Group Co., Ltd. Business Overview Table 101. Shandong Fangming Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Shandong Fangming Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio Table 103. Shandong Fangming Pharmaceutical Group Co., Ltd. Recent Development Table 104. Lunan Beite Pharmaceutical Co., Ltd. Company Information Table 105. Lunan Beite Pharmaceutical Co., Ltd. Business Overview Table 106. Lunan Beite Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Lunan Beite Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio Table 108. Lunan Beite Pharmaceutical Co., Ltd. Recent Development Table 109. Jiangxi Huiren Pharmaceutical Co., Ltd. Company Information Table 110. Jiangxi Huiren Pharmaceutical Co., Ltd. Business Overview Table 111. Jiangxi Huiren Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Jiangxi Huiren Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio Table 113. Jiangxi Huiren Pharmaceutical Co., Ltd. Recent Development Table 114. Jiangsu Jibei Pharmaceutical Co., Ltd. Company Information Table 115. Jiangsu Jibei Pharmaceutical Co., Ltd. Business Overview Table 116. Jiangsu Jibei Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Jiangsu Jibei Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio Table 118. Jiangsu Jibei Pharmaceutical Co., Ltd. Recent Development Table 119. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Company Information Table 120. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Business Overview Table 121. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio Table 123. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Recent Development Table 124. China Resources Double Crane Pharmaceutical Co., Ltd. Company Information Table 125. China Resources Double Crane Pharmaceutical Co., Ltd. Business Overview Table 126. China Resources Double Crane Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. China Resources Double Crane Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio Table 128. China Resources Double Crane Pharmaceutical Co., Ltd. Recent Development Table 129. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Company Information Table 130. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Business Overview Table 131. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio Table 133. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Recent Development Table 134. Hainan Asia Pharmaceutical Co., Ltd. Company Information Table 135. Hainan Asia Pharmaceutical Co., Ltd. Business Overview Table 136. Hainan Asia Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Hainan Asia Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio Table 138. Hainan Asia Pharmaceutical Co., Ltd. Recent Development Table 139. Guangdong Annuo Pharmaceutical Co., Ltd. Company Information Table 140. Guangdong Annuo Pharmaceutical Co., Ltd. Business Overview Table 141. Guangdong Annuo Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Guangdong Annuo Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio Table 143. Guangdong Annuo Pharmaceutical Co., Ltd. Recent Development Table 144. Disa Pharmaceutical Group Co., Ltd. Company Information Table 145. Disa Pharmaceutical Group Co., Ltd. Business Overview Table 146. Disa Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Disa Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio Table 148. Disa Pharmaceutical Group Co., Ltd. Recent Development Table 149. Chenxin Pharmaceutical Co., Ltd. Company Information Table 150. Chenxin Pharmaceutical Co., Ltd. Business Overview Table 151. Chenxin Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. Chenxin Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio Table 153. Chenxin Pharmaceutical Co., Ltd. Recent Development Table 154. Taj Pharmaceuticals Limited Company Information Table 155. Taj Pharmaceuticals Limited Business Overview Table 156. Taj Pharmaceuticals Limited Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 157. Taj Pharmaceuticals Limited Gastrointestinal Motility Drugs Product Portfolio Table 158. Taj Pharmaceuticals Limited Recent Development Table 159. Sumitomo Pharma Co., Ltd. Company Information Table 160. Sumitomo Pharma Co., Ltd. Business Overview Table 161. Sumitomo Pharma Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 162. Sumitomo Pharma Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio Table 163. Sumitomo Pharma Co., Ltd. Recent Development Table 164. Pfizer Company Information Table 165. Pfizer Business Overview Table 166. Pfizer Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 167. Pfizer Gastrointestinal Motility Drugs Product Portfolio Table 168. Pfizer Recent Development Table 169. Midas Pharma GmbH Company Information Table 170. Midas Pharma GmbH Business Overview Table 171. Midas Pharma GmbH Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 172. Midas Pharma GmbH Gastrointestinal Motility Drugs Product Portfolio Table 173. Midas Pharma GmbH Recent Development Table 174. Janssen Pharmaceutica Company Information Table 175. Janssen Pharmaceutica Business Overview Table 176. Janssen Pharmaceutica Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 177. Janssen Pharmaceutica Gastrointestinal Motility Drugs Product Portfolio Table 178. Janssen Pharmaceutica Recent Development Table 179. Hanmi Pharm. Co., Ltd. Company Information Table 180. Hanmi Pharm. Co., Ltd. Business Overview Table 181. Hanmi Pharm. Co., Ltd. Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 182. Hanmi Pharm. Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio Table 183. Hanmi Pharm. Co., Ltd. Recent Development Table 184. ANI Pharmaceuticals, Inc. Company Information Table 185. ANI Pharmaceuticals, Inc. Business Overview Table 186. ANI Pharmaceuticals, Inc. Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 187. ANI Pharmaceuticals, Inc. Gastrointestinal Motility Drugs Product Portfolio Table 188. ANI Pharmaceuticals, Inc. Recent Development Table 189. Abbott Company Information Table 190. Abbott Business Overview Table 191. Abbott Gastrointestinal Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 192. Abbott Gastrointestinal Motility Drugs Product Portfolio Table 193. Abbott Recent Development Table 194. North America Gastrointestinal Motility Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 195. North America Gastrointestinal Motility Drugs Sales by Country (2021-2026) & (K Units) Table 196. North America Gastrointestinal Motility Drugs Sales Market Share by Country (2021-2026) Table 197. North America Gastrointestinal Motility Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 198. North America Gastrointestinal Motility Drugs Sales Market Share Forecast by Country (2027-2032) Table 199. North America Gastrointestinal Motility Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 200. North America Gastrointestinal Motility Drugs Market Size by Country (2021-2026) & (US$ Million) Table 201. North America Gastrointestinal Motility Drugs Market Share by Country (2021-2026) Table 202. North America Gastrointestinal Motility Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 203. North America Gastrointestinal Motility Drugs Market Share Forecast by Country (2027-2032) Table 204. Europe Gastrointestinal Motility Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 205. Europe Gastrointestinal Motility Drugs Sales by Country (2021-2026) & (K Units) Table 206. Europe Gastrointestinal Motility Drugs Sales Market Share by Country (2021-2026) Table 207. Europe Gastrointestinal Motility Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 208. Europe Gastrointestinal Motility Drugs Sales Market Share Forecast by Country (2027-2032) Table 209. Europe Gastrointestinal Motility Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 210. Europe Gastrointestinal Motility Drugs Market Size by Country (2021-2026) & (US$ Million) Table 211. Europe Gastrointestinal Motility Drugs Market Share by Country (2021-2026) Table 212. Europe Gastrointestinal Motility Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 213. Europe Gastrointestinal Motility Drugs Market Share Forecast by Country (2027-2032) Table 214. Asia-Pacific Gastrointestinal Motility Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 215. Asia-Pacific Gastrointestinal Motility Drugs Sales by Country (2021-2026) & (K Units) Table 216. Asia-Pacific Gastrointestinal Motility Drugs Sales Market Share by Country (2021-2026) Table 217. Asia-Pacific Gastrointestinal Motility Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 218. Asia-Pacific Gastrointestinal Motility Drugs Sales Market Share Forecast by Country (2027-2032) Table 219. Asia-Pacific Gastrointestinal Motility Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 220. Asia-Pacific Gastrointestinal Motility Drugs Market Size by Country (2021-2026) & (US$ Million) Table 221. Asia-Pacific Gastrointestinal Motility Drugs Market Share by Country (2021-2026) Table 222. Asia-Pacific Gastrointestinal Motility Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 223. Asia-Pacific Gastrointestinal Motility Drugs Market Share Forecast by Country (2027-2032) Table 224. Latin America Gastrointestinal Motility Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 225. Latin America Gastrointestinal Motility Drugs Sales by Country (2021-2026) & (K Units) Table 226. Latin America Gastrointestinal Motility Drugs Sales Market Share by Country (2021-2026) Table 227. Latin America Gastrointestinal Motility Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 228. Latin America Gastrointestinal Motility Drugs Sales Market Share Forecast by Country (2027-2032) Table 229. Latin America Gastrointestinal Motility Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 230. Latin America Gastrointestinal Motility Drugs Market Size by Country (2021-2026) & (US$ Million) Table 231. Latin America Gastrointestinal Motility Drugs Market Share by Country (2021-2026) Table 232. Latin America Gastrointestinal Motility Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 233. Latin America Gastrointestinal Motility Drugs Market Share Forecast by Country (2027-2032) Table 234. Middle East and Africa Gastrointestinal Motility Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 235. Middle East and Africa Gastrointestinal Motility Drugs Sales by Country (2021-2026) & (K Units) Table 236. Middle East and Africa Gastrointestinal Motility Drugs Sales Market Share by Country (2021-2026) Table 237. Middle East and Africa Gastrointestinal Motility Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 238. Middle East and Africa Gastrointestinal Motility Drugs Sales Market Share Forecast by Country (2027-2032) Table 239. Middle East and Africa Gastrointestinal Motility Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 240. Middle East and Africa Gastrointestinal Motility Drugs Market Size by Country (2021-2026) & (US$ Million) Table 241. Middle East and Africa Gastrointestinal Motility Drugs Market Share by Country (2021-2026) Table 242. Middle East and Africa Gastrointestinal Motility Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 243. Middle East and Africa Gastrointestinal Motility Drugs Market Share Forecast by Country (2027-2032) Table 244. Key Raw Materials Table 245. Raw Materials Key Suppliers Table 246. Gastrointestinal Motility Drugs Distributors List Table 247. Gastrointestinal Motility Drugs Customers List Table 248. Research Programs/Design for This Report Table 249. Authors List of This Report Table 250. Secondary Sources Table 251. Primary Sources List of Figures Figure 1. Gastrointestinal Motility Drugs Image Figure 2. Global Gastrointestinal Motility Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gastrointestinal Motility Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Gastrointestinal Motility Drugs Sales (2021-2032) & (K Units) Figure 5. Domperidone Image Figure 6. Global Domperidone Sales YoY Growth (2021-2032) & (K Units) Figure 7. Metoclopramide Image Figure 8. Global Metoclopramide Sales YoY Growth (2021-2032) & (K Units) Figure 9. Mosapride Image Figure 10. Global Mosapride Sales YoY Growth (2021-2032) & (K Units) Figure 11. Minaprocaine Bromide Image Figure 12. Global Minaprocaine Bromide Sales YoY Growth (2021-2032) & (K Units) Figure 13. Itopride Image Figure 14. Global Itopride Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Gastrointestinal Motility Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Gastrointestinal Motility Drugs Market Share by Type 2025 VS 2032 Figure 17. North America Gastrointestinal Motility Drugs Sales Market Share in Volume by Type in 2025 Figure 18. North America Gastrointestinal Motility Drugs Sales Market Share in Value by Type in 2025 Figure 19. Europe Gastrointestinal Motility Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Europe Gastrointestinal Motility Drugs Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Gastrointestinal Motility Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Gastrointestinal Motility Drugs Sales Market Share in Value by Type in 2025 Figure 23. Latin America Gastrointestinal Motility Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Gastrointestinal Motility Drugs Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Gastrointestinal Motility Drugs Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Gastrointestinal Motility Drugs Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Gastrointestinal Motility Drugs Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Clinic Image Figure 30. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 31. Hospital Image Figure 32. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 33. Other Image Figure 34. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Gastrointestinal Motility Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Gastrointestinal Motility Drugs Market Share by Application 2025 VS 2032 Figure 37. North America Gastrointestinal Motility Drugs Sales Market Share in Volume by Application in 2025 Figure 38. North America Gastrointestinal Motility Drugs Sales Market Share in Value by Application in 2025 Figure 39. Europe Gastrointestinal Motility Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Europe Gastrointestinal Motility Drugs Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Gastrointestinal Motility Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Gastrointestinal Motility Drugs Sales Market Share in Value by Application in 2025 Figure 43. Latin America Gastrointestinal Motility Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Gastrointestinal Motility Drugs Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Gastrointestinal Motility Drugs Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Gastrointestinal Motility Drugs Sales Market Share in Value by Application in 2025 Figure 47. North America Gastrointestinal Motility Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Gastrointestinal Motility Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Gastrointestinal Motility Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Gastrointestinal Motility Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Gastrointestinal Motility Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Gastrointestinal Motility Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Gastrointestinal Motility Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Gastrointestinal Motility Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Gastrointestinal Motility Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Gastrointestinal Motility Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Gastrointestinal Motility Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Gastrointestinal Motility Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Gastrointestinal Motility Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Gastrointestinal Motility Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Gastrointestinal Motility Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Gastrointestinal Motility Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Gastrointestinal Motility Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Gastrointestinal Motility Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Gastrointestinal Motility Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Gastrointestinal Motility Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Gastrointestinal Motility Drugs Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Gastrointestinal Motility Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Domperidone
  • Metoclopramide
  • Mosapride
  • Minaprocaine Bromide
  • Itopride
Applications
  • Clinic
  • Hospital
  • Other
Companies covered
  • Zhuhai Rundu Pharmaceutical Co., Ltd.
  • Yabao Pharmaceutical Group Co., Ltd.
  • Sichuan Zilinggong Pharmaceutical Co., Ltd.
  • Shijiazhuang Siyao Co., Ltd.
  • Shandong Xinhua Pharmaceutical Co., Ltd.
  • Shandong Fangming Pharmaceutical Group Co., Ltd.
  • Lunan Beite Pharmaceutical Co., Ltd.
  • Jiangxi Huiren Pharmaceutical Co., Ltd.
  • Jiangsu Jibei Pharmaceutical Co., Ltd.
  • Jiangsu Hausen Pharmaceutical Group Co., Ltd.
  • China Resources Double Crane Pharmaceutical Co., Ltd.
  • Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd.
  • Hainan Asia Pharmaceutical Co., Ltd.
  • Guangdong Annuo Pharmaceutical Co., Ltd.
  • Disa Pharmaceutical Group Co., Ltd.
  • Chenxin Pharmaceutical Co., Ltd.
  • Taj Pharmaceuticals Limited
  • Sumitomo Pharma Co., Ltd.
  • Pfizer
  • Midas Pharma GmbH
  • Janssen Pharmaceutica
  • Hanmi Pharm. Co., Ltd.
  • ANI Pharmaceuticals, Inc.
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Gastrointestinal Motility Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Gastrointestinal Motility Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Gastrointestinal Motility Drugs Market by Type
  6. 1.3.1 Domperidone
  7. 1.3.2 Metoclopramide
  8. 1.3.3 Mosapride
  9. 1.3.4 Minaprocaine Bromide
  10. 1.3.5 Itopride
  11. 1.4 Global Gastrointestinal Motility Drugs Market Size by Type
  12. 1.4.1 Global Gastrointestinal Motility Drugs Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Gastrointestinal Motility Drugs Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Gastrointestinal Motility Drugs Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Gastrointestinal Motility Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Gastrointestinal Motility Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Gastrointestinal Motility Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Gastrointestinal Motility Drugs Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Gastrointestinal Motility Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Gastrointestinal Motility Drugs Industry Trends
  2. 2.2 Gastrointestinal Motility Drugs Industry Drivers
  3. 2.3 Gastrointestinal Motility Drugs Industry Opportunities and Challenges
  4. 2.4 Gastrointestinal Motility Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Gastrointestinal Motility Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Gastrointestinal Motility Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Gastrointestinal Motility Drugs Price (2021-2026)
  4. 3.4 Global Gastrointestinal Motility Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Gastrointestinal Motility Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Gastrointestinal Motility Drugs Company, Product Type & Application
  7. 3.7 Global Gastrointestinal Motility Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Gastrointestinal Motility Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Gastrointestinal Motility Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Gastrointestinal Motility Drugs Tier 1, Tier 2, and Tier 3
4 Gastrointestinal Motility Drugs Regional Status and Outlook
  1. 4.1 Global Gastrointestinal Motility Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Gastrointestinal Motility Drugs Historic Market Size by Region
  3. 4.2.1 Global Gastrointestinal Motility Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Gastrointestinal Motility Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Gastrointestinal Motility Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Gastrointestinal Motility Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Gastrointestinal Motility Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Gastrointestinal Motility Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Gastrointestinal Motility Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Gastrointestinal Motility Drugs by Application
  1. 5.1 Gastrointestinal Motility Drugs Market by Application
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Other
  5. 5.2 Global Gastrointestinal Motility Drugs Market Size by Application
  6. 5.2.1 Global Gastrointestinal Motility Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Gastrointestinal Motility Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Gastrointestinal Motility Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Gastrointestinal Motility Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Gastrointestinal Motility Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Gastrointestinal Motility Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Gastrointestinal Motility Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Gastrointestinal Motility Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Zhuhai Rundu Pharmaceutical Co., Ltd.
  2. 6.1.1 Zhuhai Rundu Pharmaceutical Co., Ltd. Company Information
  3. 6.1.2 Zhuhai Rundu Pharmaceutical Co., Ltd. Business Overview
  4. 6.1.3 Zhuhai Rundu Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Zhuhai Rundu Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
  6. 6.1.5 Zhuhai Rundu Pharmaceutical Co., Ltd. Recent Developments
  7. 6.2 Yabao Pharmaceutical Group Co., Ltd.
  8. 6.2.1 Yabao Pharmaceutical Group Co., Ltd. Company Information
  9. 6.2.2 Yabao Pharmaceutical Group Co., Ltd. Business Overview
  10. 6.2.3 Yabao Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Yabao Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
  12. 6.2.5 Yabao Pharmaceutical Group Co., Ltd. Recent Developments
  13. 6.3 Sichuan Zilinggong Pharmaceutical Co., Ltd.
  14. 6.3.1 Sichuan Zilinggong Pharmaceutical Co., Ltd. Company Information
  15. 6.3.2 Sichuan Zilinggong Pharmaceutical Co., Ltd. Business Overview
  16. 6.3.3 Sichuan Zilinggong Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sichuan Zilinggong Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
  18. 6.3.5 Sichuan Zilinggong Pharmaceutical Co., Ltd. Recent Developments
  19. 6.4 Shijiazhuang Siyao Co., Ltd.
  20. 6.4.1 Shijiazhuang Siyao Co., Ltd. Company Information
  21. 6.4.2 Shijiazhuang Siyao Co., Ltd. Business Overview
  22. 6.4.3 Shijiazhuang Siyao Co., Ltd. Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Shijiazhuang Siyao Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
  24. 6.4.5 Shijiazhuang Siyao Co., Ltd. Recent Developments
  25. 6.5 Shandong Xinhua Pharmaceutical Co., Ltd.
  26. 6.5.1 Shandong Xinhua Pharmaceutical Co., Ltd. Company Information
  27. 6.5.2 Shandong Xinhua Pharmaceutical Co., Ltd. Business Overview
  28. 6.5.3 Shandong Xinhua Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Shandong Xinhua Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
  30. 6.5.5 Shandong Xinhua Pharmaceutical Co., Ltd. Recent Developments
  31. 6.6 Shandong Fangming Pharmaceutical Group Co., Ltd.
  32. 6.6.1 Shandong Fangming Pharmaceutical Group Co., Ltd. Company Information
  33. 6.6.2 Shandong Fangming Pharmaceutical Group Co., Ltd. Business Overview
  34. 6.6.3 Shandong Fangming Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Shandong Fangming Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
  36. 6.6.5 Shandong Fangming Pharmaceutical Group Co., Ltd. Recent Developments
  37. 6.7 Lunan Beite Pharmaceutical Co., Ltd.
  38. 6.7.1 Lunan Beite Pharmaceutical Co., Ltd. Company Information
  39. 6.7.2 Lunan Beite Pharmaceutical Co., Ltd. Business Overview
  40. 6.7.3 Lunan Beite Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Lunan Beite Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
  42. 6.7.5 Lunan Beite Pharmaceutical Co., Ltd. Recent Developments
  43. 6.8 Jiangxi Huiren Pharmaceutical Co., Ltd.
  44. 6.8.1 Jiangxi Huiren Pharmaceutical Co., Ltd. Company Information
  45. 6.8.2 Jiangxi Huiren Pharmaceutical Co., Ltd. Business Overview
  46. 6.8.3 Jiangxi Huiren Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Jiangxi Huiren Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
  48. 6.8.5 Jiangxi Huiren Pharmaceutical Co., Ltd. Recent Developments
  49. 6.9 Jiangsu Jibei Pharmaceutical Co., Ltd.
  50. 6.9.1 Jiangsu Jibei Pharmaceutical Co., Ltd. Company Information
  51. 6.9.2 Jiangsu Jibei Pharmaceutical Co., Ltd. Business Overview
  52. 6.9.3 Jiangsu Jibei Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Jiangsu Jibei Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
  54. 6.9.5 Jiangsu Jibei Pharmaceutical Co., Ltd. Recent Developments
  55. 6.10 Jiangsu Hausen Pharmaceutical Group Co., Ltd.
  56. 6.10.1 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Company Information
  57. 6.10.2 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Business Overview
  58. 6.10.3 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
  60. 6.10.5 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Recent Developments
  61. 6.11 China Resources Double Crane Pharmaceutical Co., Ltd.
  62. 6.11.1 China Resources Double Crane Pharmaceutical Co., Ltd. Company Information
  63. 6.11.2 China Resources Double Crane Pharmaceutical Co., Ltd. Business Overview
  64. 6.11.3 China Resources Double Crane Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 China Resources Double Crane Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
  66. 6.11.5 China Resources Double Crane Pharmaceutical Co., Ltd. Recent Developments
  67. 6.12 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd.
  68. 6.12.1 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Company Information
  69. 6.12.2 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Business Overview
  70. 6.12.3 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
  72. 6.12.5 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Recent Developments
  73. 6.13 Hainan Asia Pharmaceutical Co., Ltd.
  74. 6.13.1 Hainan Asia Pharmaceutical Co., Ltd. Company Information
  75. 6.13.2 Hainan Asia Pharmaceutical Co., Ltd. Business Overview
  76. 6.13.3 Hainan Asia Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Hainan Asia Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
  78. 6.13.5 Hainan Asia Pharmaceutical Co., Ltd. Recent Developments
  79. 6.14 Guangdong Annuo Pharmaceutical Co., Ltd.
  80. 6.14.1 Guangdong Annuo Pharmaceutical Co., Ltd. Company Information
  81. 6.14.2 Guangdong Annuo Pharmaceutical Co., Ltd. Business Overview
  82. 6.14.3 Guangdong Annuo Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Guangdong Annuo Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
  84. 6.14.5 Guangdong Annuo Pharmaceutical Co., Ltd. Recent Developments
  85. 6.15 Disa Pharmaceutical Group Co., Ltd.
  86. 6.15.1 Disa Pharmaceutical Group Co., Ltd. Company Information
  87. 6.15.2 Disa Pharmaceutical Group Co., Ltd. Business Overview
  88. 6.15.3 Disa Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Disa Pharmaceutical Group Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
  90. 6.15.5 Disa Pharmaceutical Group Co., Ltd. Recent Developments
  91. 6.16 Chenxin Pharmaceutical Co., Ltd.
  92. 6.16.1 Chenxin Pharmaceutical Co., Ltd. Company Information
  93. 6.16.2 Chenxin Pharmaceutical Co., Ltd. Business Overview
  94. 6.16.3 Chenxin Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Chenxin Pharmaceutical Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
  96. 6.16.5 Chenxin Pharmaceutical Co., Ltd. Recent Developments
  97. 6.17 Taj Pharmaceuticals Limited
  98. 6.17.1 Taj Pharmaceuticals Limited Company Information
  99. 6.17.2 Taj Pharmaceuticals Limited Business Overview
  100. 6.17.3 Taj Pharmaceuticals Limited Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Taj Pharmaceuticals Limited Gastrointestinal Motility Drugs Product Portfolio
  102. 6.17.5 Taj Pharmaceuticals Limited Recent Developments
  103. 6.18 Sumitomo Pharma Co., Ltd.
  104. 6.18.1 Sumitomo Pharma Co., Ltd. Company Information
  105. 6.18.2 Sumitomo Pharma Co., Ltd. Business Overview
  106. 6.18.3 Sumitomo Pharma Co., Ltd. Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Sumitomo Pharma Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
  108. 6.18.5 Sumitomo Pharma Co., Ltd. Recent Developments
  109. 6.19 Pfizer
  110. 6.19.1 Pfizer Company Information
  111. 6.19.2 Pfizer Business Overview
  112. 6.19.3 Pfizer Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Pfizer Gastrointestinal Motility Drugs Product Portfolio
  114. 6.19.5 Pfizer Recent Developments
  115. 6.20 Midas Pharma GmbH
  116. 6.20.1 Midas Pharma GmbH Company Information
  117. 6.20.2 Midas Pharma GmbH Business Overview
  118. 6.20.3 Midas Pharma GmbH Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Midas Pharma GmbH Gastrointestinal Motility Drugs Product Portfolio
  120. 6.20.5 Midas Pharma GmbH Recent Developments
  121. 6.21 Janssen Pharmaceutica
  122. 6.21.1 Janssen Pharmaceutica Company Information
  123. 6.21.2 Janssen Pharmaceutica Business Overview
  124. 6.21.3 Janssen Pharmaceutica Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Janssen Pharmaceutica Gastrointestinal Motility Drugs Product Portfolio
  126. 6.21.5 Janssen Pharmaceutica Recent Developments
  127. 6.22 Hanmi Pharm. Co., Ltd.
  128. 6.22.1 Hanmi Pharm. Co., Ltd. Company Information
  129. 6.22.2 Hanmi Pharm. Co., Ltd. Business Overview
  130. 6.22.3 Hanmi Pharm. Co., Ltd. Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 Hanmi Pharm. Co., Ltd. Gastrointestinal Motility Drugs Product Portfolio
  132. 6.22.5 Hanmi Pharm. Co., Ltd. Recent Developments
  133. 6.23 ANI Pharmaceuticals, Inc.
  134. 6.23.1 ANI Pharmaceuticals, Inc. Company Information
  135. 6.23.2 ANI Pharmaceuticals, Inc. Business Overview
  136. 6.23.3 ANI Pharmaceuticals, Inc. Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2021-2026)
  137. 6.23.4 ANI Pharmaceuticals, Inc. Gastrointestinal Motility Drugs Product Portfolio
  138. 6.23.5 ANI Pharmaceuticals, Inc. Recent Developments
  139. 6.24 Abbott
  140. 6.24.1 Abbott Company Information
  141. 6.24.2 Abbott Business Overview
  142. 6.24.3 Abbott Gastrointestinal Motility Drugs Sales, Revenue and Gross Margin (2021-2026)
  143. 6.24.4 Abbott Gastrointestinal Motility Drugs Product Portfolio
  144. 6.24.5 Abbott Recent Developments
7 North America by Country
  1. 7.1 North America Gastrointestinal Motility Drugs Sales by Country
  2. 7.1.1 North America Gastrointestinal Motility Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Gastrointestinal Motility Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Gastrointestinal Motility Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Gastrointestinal Motility Drugs Market Size by Country
  6. 7.2.1 North America Gastrointestinal Motility Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Gastrointestinal Motility Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Gastrointestinal Motility Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Gastrointestinal Motility Drugs Sales by Country
  2. 8.1.1 Europe Gastrointestinal Motility Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Gastrointestinal Motility Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Gastrointestinal Motility Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Gastrointestinal Motility Drugs Market Size by Country
  6. 8.2.1 Europe Gastrointestinal Motility Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Gastrointestinal Motility Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Gastrointestinal Motility Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Gastrointestinal Motility Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Gastrointestinal Motility Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Gastrointestinal Motility Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Gastrointestinal Motility Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Gastrointestinal Motility Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Gastrointestinal Motility Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Gastrointestinal Motility Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Gastrointestinal Motility Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Gastrointestinal Motility Drugs Sales by Country
  2. 10.1.1 South America Gastrointestinal Motility Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Gastrointestinal Motility Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Gastrointestinal Motility Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Gastrointestinal Motility Drugs Market Size by Country
  6. 10.2.1 South America Gastrointestinal Motility Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Gastrointestinal Motility Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Gastrointestinal Motility Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Gastrointestinal Motility Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Gastrointestinal Motility Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Gastrointestinal Motility Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Gastrointestinal Motility Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Gastrointestinal Motility Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Gastrointestinal Motility Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Gastrointestinal Motility Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Gastrointestinal Motility Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Gastrointestinal Motility Drugs Value Chain Analysis
  2. 12.1.1 Gastrointestinal Motility Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Gastrointestinal Motility Drugs Production Mode & Process
  7. 12.2 Gastrointestinal Motility Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Gastrointestinal Motility Drugs Distributors
  10. 12.2.3 Gastrointestinal Motility Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst